Genesis Healthcare, Inc. (GEN): $0.42

-0.06 (-12.71%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Genesis Healthcare Inc (GEN) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Genesis Healthcare Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2 $0.57 $0.5 $0.54 $0.42 28.57%

The Trend in the Analyst Price Target


Over the past 33 days, GEN's average price target has gone down $0.

GEN reports an average of 2.92% for its upside potential over the past 302 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-05-27 2 2.00 1.20 1.600 1.010 58.42%
2020-08-11 2 2.00 0.75 1.380 0.756 82.54%
2020-09-04 1 0.75 0.75 0.750 0.633 18.48%
2020-10-25 1 0.75 0.75 0.750 0.460 63.04%
2020-11-10 1 0.57 0.57 0.570 0.489 16.56%
2020-11-17 2 0.57 0.50 0.535 0.481 11.23%
2020-12-07 2 0.57 0.50 0.540 0.508 6.3%
2020-12-09 2 0.57 0.50 0.540 0.524 3.05%
2020-12-19 2 0.57 0.50 0.540 0.540 0%
2020-12-26 2 0.57 0.50 0.540 0.542 -0.37%
2021-01-02 2 0.57 0.50 0.540 0.485 11.34%
2021-01-09 2 0.57 0.50 0.540 0.590 -8.47%
2021-01-16 2 0.57 0.50 0.540 0.726 -25.62%
2021-01-23 2 0.57 0.50 0.540 0.721 -25.1%
2021-01-30 2 0.57 0.50 0.540 0.673 -19.76%
2021-02-06 2 0.57 0.50 0.540 0.781 -30.86%
2021-02-13 2 0.57 0.50 0.540 1.020 -47.06%
2021-02-20 2 0.57 0.50 0.540 0.936 -42.31%
2021-02-27 2 0.57 0.50 0.540 0.793 -31.9%
2021-03-06 2 0.57 0.50 0.540 0.479 12.73%
2021-03-13 2 0.57 0.50 0.540 0.561 -3.74%
2021-03-20 2 0.57 0.50 0.540 0.600 -10%
2021-03-25 2 0.57 0.50 0.540 0.420 28.57%

GEN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.25 0 0 1 0 0 2

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • GEN has a greater average analyst price target than 0.2% of all US stocks.
  • The number of analysts covering the stock of GEN is greater than 13.95% of Healthcare stocks.
  • The variance in analysts' estimates of GEN is lower than 77.76% of Healthcare stocks.
  • The upside potential (average analyst target price relative to current price) of GEN is greater than 69.02% of all US stocks.

In the Healthcare industry, BKD, CSU and MGLN are the three stocks most similar to Genesis Healthcare Inc regarding the price target and analyst recommendation information presented here.

Is GEN a Buy, Hold or Sell? See the POWR Ratings now!



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8605 seconds.